Elucidating the molecular mechanisms of TGF‐β in the development of kidney diseases and renal cancer will facilitate the identification of novel diagnostic biomarkers and therapeutic targets, offering new perspectives for the prevention and treatment of renal cancer. The gene discussed is TGFB1; the disease is renal carcinoma.